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ABSTRACT
OBJECTIVE: To describe the Reference Centers for Special Immunobiologicals and evaluate 
their implementation considering formal regulations. 
METHODS: We conducted a program evaluation, of evaluative research type. From August 
2011 to January 2012, a questionnaire was applied to the 42 Reference Centers for Special 
Immunobiologicals existing in the Country, approaching the structure, human resources, 
and developed activities dimensions. We conducted a descriptive analysis of data and used a 
clustering for binary data with the squared Euclidean distance, by the farthest neighbor method, 
to aggregate services with similar features. 
RESULTS: We observed great diversity among the services in the three dimensions. The clustering 
resulted in five service profiles, named according to their characteristics. 1) Best structure: 
12 Reference Centers for Special Immunobiologicals with the highest proportion of services 
with the minimum of rooms recommended, purpose-built vaccine refrigerators, preventive 
maintenance of the cold chain, and oxygen source. 2) Immunobiologicals distributor: six Reference 
Centers for Special Immunobiologicals that distributed more than applied immunogens; 
no doctor present for more than half of the working hours and no purpose-built vaccine 
refrigerators . 3) Incipient implementation: five Reference Centers for Special Immunobiologicals 
with inadequate structure, such as absence of purpose-built vaccine refrigerators, preventive 
maintenance of the cold chain and oxygen source; none had computer. 4) Vaccination rooms: 
13 Reference Centers for Special Immunobiologicals, everyone did routine immunization, most 
participated in vaccination campaigns. 5) Teaching and research: six services, all inserted into 
teaching hospitals, developed researches and received trainees; most had doctors in more than 
half of the working hours. 
CONCLUSIONS: The evaluation of the Reference Centers for Special Immunobiologicals 
implementation was based on the profiles found and considered the official regulations: services 
categorized as “better structure” and “teaching and research” were considered implemented; 
“immunobiologicals distributor” and “vaccination room” services, partially implemented, and the 
ones with the “incipient implementation” profile, not implemented. The results of this evaluation 
can contribute to the reformulation of the services, considering the current context.
DESCRIPTORS: Immunization. Health Centers. Immunization Programs, organization & 
administration. Vaccines, supply & distribution. Program Evaluation. Health Services Evaluation. 
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INTRODUCTION
Patients with chronic diseases, such as immune deficiencies (congenital or acquired), 
neurological, hematological, and metabolic disorders, heart diseases, lung diseases, and 
others, or with exposure to risk situations, have a higher risk of infection or severe illness 
by certain pathogens and have recommendations for specific immunizations15,24,25. Several 
countries, such as United Kingdom, France, Germany, United States, Mexico, and Argentina, 
have established vaccination calendars for these individuals1,2,4,7,8,13. 
To meet these special groups in Brazil, the Programa Nacional de Imunizações (PNI – National 
Immunization Program) created the Reference Centers for Special Immunobiologicals 
(CRIE), which are public and free vaccination units. These Centers provide vaccines and 
immunoglobulins not available on the PNI routine for individuals with a higher risk of infection 
or severe illness, and for those with contraindication of immunobiologicals used routinely. 
Besides, the CRIE are also responsible for the investigation and follow-up of cases of adverse 
events following immunization (AEFI)15. The first services were created in 1993. Until 2000, 
34 CRIE were created and, since 2002, each Brazilian state has at least one of these services16. 
Several publications discuss indications of special immunobiologicals or describe the 
care to specific groups in the CRIE3,5,6,21,24,26, but we did not find studies that evaluate the 
implementation of CRIE in national perspective. 
The aim of this study was to describe the CRIE existing in Brazil, in 2011, and evaluate 
if their implementation occurred in accordance with the guidelines and regulations 
established by PNI.
METHODS
The methodology adopted in the study was evaluation of health program of evaluative 
research type19. All managers of the 42 CRIE in the Country were invited to participate, 
identified by a list provided by the PNI General Coordination in June 2011. In 21 states, only 
one CRIE was identified, located in the capital. Six states and the Federal District had more 
than one service: Para (two), Bahia (two), Federal District ( four), Sao Paulo (seven), Rio de 
Janeiro (three), and Rio Grande do Sul (three).
The CRIE are under the coordination of three instances: Brazilian Ministry of Health, by the 
PNI; State Secretariats of Health (SES); and the institution in which they are located (local 
level, usually higher complexity hospitals). The functioning and operation of CRIEs follow 
the Ordinance 48, from July 28, 2004a, which sets the minimum structure and the necessary 
human resources, also considering possible emergency care, since the target audience 
includes individuals with increased risk of presenting adverse events following immunization. 
The operation must occur on a time that allows the application of immunobiologicals (or their 
distribution to application in other service) in cases of urgency, as prophylaxis after exposure. 
The indications of immunobiologicals follow the PNI recommendations, listed in the CRIE 
Manual, revised and updated periodically by a group of experts15.
The data source was a semi-structured questionnaire developed for this study, consisting 
of 170 questions. The following program dimensions were studied: structure (existence of 
minimal physical area, institution in which it is inserted, equipment and inputs), human 
resources (number and training of professionals, workload, training for emergency care), and 
developed activities (application of immunobiologicals and their distribution to be applied in 
another service, assistance for adverse events following immunization, teaching and research 
activities). The regulations of the Ordinance that establishes general guidelines for CRIE 
operation guided the formulation of the questions, and the questionnaire was reviewed by 
the Technical Advisory of the General Coordination of PNI and by the Technical Management 
of Support to CRIE Management from the General Coordination of PNI.
a Ministério da Saúde, Secretaria 
de Vigilância em Saúde. Portaria 
nº 48, de 28 de julho de 2004. 
Institui diretrizes gerais para 
funcionamento dos Centros de 
Referência para Imunobiológicos 
Especiais – CRIE, define as 
competências da Secretaria de 
Vigilância em Saúde, dos Estados, 
Distrito Federal e CRIE e dá outras 
providências. Diario Oficial 
Uniao. 29 jul 2004;seção 1:63. 
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The questionnaire was available in online platform (virtual environment), from August 
2011 to January 2012, and answered by the managers of the CRIE, or their substitutes, after 
agreement by signing the informed consent form. The project was approved by the Research 
Ethics Committee of the Hospital das Clinicas of Faculdade de Medicina of Universidade de 
São Paulo (Protocol of research 0281/10).
In the descriptive analysis, we estimated the simple frequencies of the answers for the 
characterization of the services. To create service profiles with similar characteristics, 
we selected nuclear issues in the three evaluated dimensions and performed the analysis 
using the clustering for binary data with the squared Euclidean distance, by the furthest 
neighbor method (complete linkage). This technique allows one to move successively in the 
algorithm by clustering small groups in larger ones, according to the values of the squared 
Euclidean distance, producing a tree of groups named dendrogram. The cutoff level in the 
dendrogram is defined by the researcher and must represent the most suitable number of 
groups, in accordance with the research goals9.
RESULTS
All 42 CRIE filled the questionnaire, with varying completeness and quality. 
Figure 1 presents the number of immunobiologicals doses applied by the CRIE, from 2006 to 2010, 
by region and year (nine CRIE without information). In 2010, the CRIE accounted for 518,964 
immunobiologicals doses applied. The record was made by applied doses and each person could 
receive more than one immunobiological. Few services (21.0%) recorded the attended cases 
in which the required immunobiological was not released. The total number of applied doses 
increased 66.0% in the studied period; but this increase was not uniform, being higher in the 
Northeast (118.0%), followed by South (87.0%), and Southeast (63.0%). In the North and Midwest 
there was not increase in the number of applied doses; however, this datum was not informed by 10 
(59.0%) services of these regions. Thirty-five CRIE (83.0%) mentioned applying immunobiologicals 
of the PNI routine calendar and 31 (74.0%) reported participating in vaccination campaigns.
The 40 CRIE (95.0%) reported that they rendered assistance to adverse events following 
events; 36 (86.0%) mentioned counting on support of experts for this service; 34 (81.0%), 
with hospital support; and 28 (67.0%), with laboratory support (Table). 
CRIE without information: 9
Figure 1. Number of immunobiologicals doses applied in the Reference Centers for Special 
Immunobiologicals (CRIE), by region and year, in the period from 2006 to 2010.
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G1: best structure; G2: immunobiologicals distributor; G3: incipient implementation; G4: vaccination room; G5: teaching and research
a Questions used in the statistical clustering for the creation of CRIE profiles.
b Characteristics not included in the creation of the profiles.
Table. Structural and human resources characteristics and developed activities in the Reference Centers for Special Immunobiologicals 
(CRIE) in accordance with the services and distribution profiles (%) of the structural and human resources characteristics and developed 
activities. Brazil, 2011.
Characteristics
Profile
G1 G2 G3 G4 G5 Total
(n = 12) (n = 6) (n = 5) (n = 13) (n = 6) (N = 42)
% % % % % %
Structure
Proportion of services that are inserted into teaching institutiona 58.0 0 0 0 100 31.0
Proportion of services that have minimal physical structure, according 
to the recommendation (reception, doctor’s office, preparation and/or 
vaccination room)a
92.0 50.0 60.0 54.0 83.0 69.0
Proportion of services that are inserted into building where other services operatea 75.0 100 80.0 92.0 100 88.1
Proportion of services that share the working area with other activitiesa 17.0 17.0 100 62.0 50.0 45.2
Proportion of services that have purpose-built vaccine refrigeratora 58.0 0 20.0 54.0 50.0 42.9
Proportion of services with preventive maintenance for cold chaina 92.0 83.0 20.0 0 83.0 52.4
Proportion of services that have electrical power generatorb 91.7 50.0 80.0 46.2 100 71.4
Proportion of services that have oxygen sourcea 92.0 33.0 20.0 69.0 17.0 57.1
Proportion of services that have computera 75.0 100 0 100 100 80.1
Proportion of services that have faxa 42.0 33.0 0 69.0 83.0 50.0
Human Resources
Proportion of services that have doctor in more than 50.0% of working hoursa 66.7 0 60.0 23.1 83.3 45.2
Proportion of services that have human resources training to meet emergenciesa 100.0 17.0 20.0 69.0 67.0 64.3
Developed activities
Proportion of services that apply routine immunobiologicalsa 92.0 33.0 60.0 100 100 83.3
Proportion of services that apply more than 80.0% of the released 
immunobiologicals in their own CRIEa
50.0 33.3 60.0 92.3 83.3 66.7
Proportion of services that participated in vaccination campaigns in the 
last 5 yearsa
67.0 83.0 80.0 69.0 83.0 73.8
Proportion of services that meet non-presential solicitations (only the requests)a 100 67.0 60.0 85.0 83.0 83.3
Proportion of services that provide a counter-reference document to the 
patient/requester, when there is no indication of immunobiologicala
100 67.0 40.0 54.0 67.0 69.0
Proportion of services that register the cases seen to which the 
immunobiological was not releasedb
16.7 16.7 20.0 23.1 33.3 21.4
Proportion of services with operation to the public more than 40 hours a weeka 58.3 66.7 40.0 84.6 50.0 59.5
Proportion of services that have available telephone contact for 24 hoursa 67.0 83.0 60.0 46.0 67.0 61.9
Proportion of services that meet people who received immunobiologicals 
in other health units and present adverse events following immunizationa
83.0 83.0 80.0 92.0 100 88.1
Proportion of services that have support of experts for cases of adverse 
events following immunizationb
91.7 100 80.0 76.9 83.3 85.7
Proportion of services that have laboratory support for cases of adverse 
events following immunizationb
83.3 83.3 40.0 61.5 50.0 66.7
Proportion of services that have hospital support for cases of adverse events 
following immunizationb
91.7 100 80.0 76.9 50.0 81.0
Proportion of services that rely on technical support Group for the 
discussion of cases of adverse events following immunizationb
58.3 0 40.0 53.8 66.7 47.6
Proportion of services that receive traineesa 75.0 33.0 60.0 85.0 100 73.8
Proportion of services that do or did researches in immunizationsa 42.0 0 0 15.0 100 31.0
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Nine services reported having no doctor, at the time of the research, and four reported lack 
of nurse. There were trained professionals for emergency care in 27 services (64.0%).
Regarding the infrastructure, lack of sufficient cold chain equipment was reported by 29 CRIE 
managers (69.0%) and 35 (83.0%) reported use of domestic refrigerators. Source of oxygen 
was available in 24 CRIE (57.0%).
In the dendrogram analysis resulting from the application of the grouping method for binary 
data, using the Euclidean distance squared, by the furthest neighbor method (complete 
linkage), to the selected data for the characterization of the services, we opted by cutting 
the squared Euclidean distance measure in 20 points. Five clusterings resulted from this, 
in which the services were considered to have relevant characteristics in common and that 
differed them from other clusterings (Figure 2).
Group 1 was named “best structure” profile, because it featured the largest number of services 
that had the minimum recommended rooms (reception, doctor’s office, and preparation 
or vaccination room). This group also showed greater proportion of services with presence 
of oxygen source, purpose-built vaccine refrigerators, and preventive maintenance of the 
cold chain. All services of this group had trained professionals to meet emergencies. Most 
received trainees, but less than half did research activities (Table).
Group 2 was named “immunobiologicals distributor” profile, for being the group with 
services that applied fewer doses of immunobiologicals in relation to the total distributed 
immunogens (administered and distributed) by the service. It also featured the lowest 
frequency of services that applied the vaccines of the routine calendars. Only half of the 
services had minimal physical structure and none of them had purpose-built vaccine 
refrigerators. It was the only group in which no CRIE had doctor present during more than half 
of the working hours. This group also showed the lowest frequency of trained professionals 
to meet emergencies.
Group 3 was named “incipient implementation” because it includes services with insufficient 
structure, according to the foreseen in the Ordinance that regulates the CRIE. None of them 
had unique physical area, few had purpose-built vaccine refrigerator and oxygen supply and 
the services had the lowest rate of preventive maintenance of the cold chain. None of these 
CRIE had computer or fax. Less than half worked more than 40 hours a week, considered 
as minimum necessary period for application and distribution of immunobiologicals 
satisfactorily in the CRIE. 
Group 4, named “vaccination room” profile, included services that showed features that were 
more similar to a conventional vaccination room. All services did routine vaccination, and 
most of them applied the majority of their immunobiologicals and participated in vaccination 
campaigns. Most services worked more than 40 hours a week. 
In Group 5, called “education and research” profile, all CRIE were inserted into teaching 
hospitals, developed research activities and received trainees. This group presented the best 
index of presence of doctors. Most services had appropriate minimum physical structure. 
All applied routine vaccines and most applied more than 80.0% of released immunobiologicals 
and participated in vaccination campaigns.
Twelve of the 18 CRIE of the “better structure” and “teaching and research” groups were 
located in the Southeast and South regions (Figure 3). From the five services of the “incipient 
implementation” profile, four were located in the Midwest region. In the North and Northeast, 
there is no evidence of the predominance of any group. 
All CRIE of the “incipient implementation” group were created before 2000, while, in the 
“better structure” and “teaching and research” groups, we observed services created at 
different times, from 1993 to 2009 (Figure 4).
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The degree of CRIE implementation was evaluated considering the Ordinance that regulates 
the services. The CRIE with the profiles called “better structure” and “teaching and research” 
were considered implemented. The CRIE with the “immunobiologicals distributor” and 
“vaccination room” profiles were considered partially implemented. The CRIE of the “incipient 
implementation” profile were considered not implemented.
CRIE: Reference Centers for Special Immunobiologicals; G1: best structure; G2: immunobiologicals distributor; 
G3: incipient implementation; G4: vaccination room; G5: teaching and research
Figure 2. Dendrogram of the clustering for binary data with the squared Euclidean distance, by the 
farthest neighbor method, with formation of five groups of services with similar features.
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Figure 3. Geographic distribution and profile (G1 to G5) of the Reference Centers for Special 
Immunobiologicals in Brazil by state, in 2011.
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Figure 4. Distribution of Reference Centers for Special Immunobiologicals (CRIE) according to the 
profile (G1 to G5) and opening year.
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DISCUSSION
This is the first systematic study that evaluated the implementation of CRIE in national 
perspective based on primary data, analyzing the structure, human resources, and developed 
activities dimensions. The data showed the diversity of the services’ situation nearly two 
decades after the creation of the special immunobiologicals program by PNI, indicating that 
the implementation of CRIE occurred without uniformity. 
Regarding the CRIE distribution across the Country, we did not observe a population 
coverage criterion for the definition of the number of services by state. According to personal 
information of state managers of immunization, distribution of these immunogens to the 
cities via Health Regions seems to have been implemented in some states, as an alternative 
to increase patients access to special immunobiologicals.
We expected to observe a relation between the time of opening of the services and the 
degree of implementation, but the results do not prove this hypothesis, because all services 
of “incipient implementation” were inaugurated for over a decade (Figure 4). On the other 
hand, there seems to be a relation between the region where the CRIE were located and the 
degree of implementation, since most CRIE of G1 and G5 were located in the Southeast, 
while most CRIE of G3 were located in the Midwest region.
Some faced barriers for the implementation of CRIE may have been caused by changes in 
policies for the Brazilian Unified Health System (SUS) over time. The conventional vaccination 
rooms were decentralized with the municipalization of health, what did not occurred with 
the CRIE. The local context of the institutions that house the CRIE, regarding the available 
structure, human resources, and their priorities, appear to have been instrumental in the 
implementation and performance of the services. 
Several factors may have contributed to the increase in the number of immunobiologicals 
doses applied by CRIE, such as: increased target audience, disclosure of the existence of CRIE 
and dissemination of knowledge about the recommendations of special immunobiologicals. 
This increase was most evident in the Northeast, followed by the South and Southeast 
regions. The absence of an increase in the number of doses applied in the North and Midwest 
regions may be due to information bias, since more than half of the services of these regions 
did not inform the number of immunobiologicals doses applied. Obstacles to the growth of 
some services may be arising from the inadequacy of the physical area, lack of cold chain 
equipment (or their inadequacy regarding regulations)14, and the lack of essential human 
resources. These factors can also impair the activities of evaluation and application of 
immunobiologicals, as well as the care of emergencies and investigation of adverse events 
following immunization. This panorama may have changed in recent years, since some 
improvements may have been implemented, such as the transfer of funds from the Ministry 
of Health to the states for adequacy of the cold chainb.
Despite the heterogeneity within the groups, the profiles called “better structure” (G1) and 
“teaching and research” (G5), which amounted to 18 services (43.0%), resembled more what 
was proposed in the Ordinance that regulates the CRIE, being considered implemented. 
The characteristics that distinguished these two groups from the others were the higher 
proportion of services with more complete structure (G1) and higher proportion of services 
that developed activities such as application of immunogens in the very CRIE, participation 
in campaigns, application of routine vaccinations, and teaching and research activities (G5).
The initial proposal for all CRIE was that they were privileged spaces for the development of 
teaching and research, training and capacity building. Some CRIE have developed studies in 
specific populations immunizations and adverse events following immunizaiton3,6,10-12,17,18,20-23. 
The CRIE that comprise the two most well-structured profiles could further develop teaching 
and research activities, counting on greater support and encouragement of the SES and the 
Ministry of Health/PNI. Meanwhile, placing the same requirements for services with very different 
conditions may hamper the identification of which activities could be considered more relevant to 
b Ministério da Saúde, Secretaria 
de Vigilância em Saúde. Portaria 
nº 3.301, de 26 de dezembro 
de 2013. Autoriza o repasse 
financeiro de investimento do 
Fundo Nacional de Saúde aos 
Fundos de Saúde Estaduais 
e Municipais para aquisição 
de equipamentos, material 
permanente e/ou unidade(s) 
móvel(is) para fomento e 
aprimoramento das condições 
de funcionamento da Rede de 
Frio. Diario Oficial Uniao. 26 dez 
2013;seção 1:256.
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the different types of CRIE. Although not presenting appropriate conditions to develop research, 
the “immunobiological distributor” and “vaccination room” profiles could invest in training and 
capacity building for health professionals in their coverage area, as well as in the strengthening 
of their main activities of application and dispensing of special immunobiologicals. The services 
with “incipient implementation” profiles require extensive adequation of the structure and human 
resources and reorganization of the developed activities to find their vocation.
Regarding the limitations of this study, the results must be analyzed with caution, since they 
were based on a questionnaire applied at a distance. With this type of assessment tool and 
without on-the-spot inspection, the responses must be treated as mentioned information 
and are subjected to the subjectivities of the respondents, related to their personal opinions 
or interpretations of the questions. Some questions were unused because they are not well 
formulated or their formatting has raised questions in the online form. Besides, the choice 
of the questions for the statistical analysis may have reflected in the final outcome of the 
implementation evaluation.
Additionally, the introduction of new vaccines into the PNI routine immunization calendar, 
such as the 10-valent pneumococcal conjugate and meningococcal C conjugate (2010), IPV 
(2012), varicella (2013), and hepatitis A (2014), may have altered the demand for vaccines in 
the CRIE. Besides, new services were created (at least three more CRIE were opened since the 
end of data collection until 2014, in Minas Gerais, Rio de Janeiro, and Acre). However, there is 
no evidence that substantial changes have occurred in the services since the data collection.
Considering that less than half of the services were classified as fully implemented, the results of 
this study may contribute to the restructuring of the services, including the review of the role of 
CRIE and reformulation of the special immunobiologicals program, based on the current context.
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